Lv2
200 积分 2025-07-30 加入
Sialic acids in cancer biology and immunity
16天前
已完结
Nanoparticle delivery to tumours: from EPR and ATR mechanisms to clinical impact
20天前
已完结
Emerging epigenetic-modulating therapies in lymphoma
23天前
已完结
Emerging epigenetic-modulating therapies in lymphoma
23天前
已关闭
Emerging epigenetic-modulating therapies in lymphoma
23天前
已关闭
Barriers and solutions for CAR-T therapy in solid tumors
23天前
已完结
Chimeric Antigen Receptor T Cells in Hodgkin and T-Cell Lymphomas
23天前
已完结
The ECHELON-2 Trial: 5-year results of a randomized, phase III study of brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma
23天前
已完结
A perspective on improving the R-CHOP regimen: from Mega-CHOP to ROBUST R-CHOP, the PHOENIX is yet to rise
24天前
已完结
Recent advances and future perspectives in frontline treatment of peripheral T-cell lymphoma
26天前
已完结
皖公网安备34019202002308
